REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 205 filers reported holding REGENXBIO INC in Q3 2018. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $690,616 | -44.5% | 59,027 | 0.0% | 0.00% | – |
Q1 2024 | $1,243,699 | +16.4% | 59,027 | -0.9% | 0.00% | – |
Q4 2023 | $1,068,743 | +6.9% | 59,540 | -1.9% | 0.00% | – |
Q3 2023 | $999,451 | -17.7% | 60,720 | 0.0% | 0.00% | – |
Q2 2023 | $1,213,793 | -42.0% | 60,720 | -45.2% | 0.00% | -100.0% |
Q1 2023 | $2,093,715 | +39.3% | 110,720 | +67.1% | 0.00% | 0.0% |
Q4 2022 | $1,503,208 | -14.2% | 66,279 | +0.1% | 0.00% | 0.0% |
Q3 2022 | $1,751,000 | +7.0% | 66,237 | -0.0% | 0.00% | 0.0% |
Q2 2022 | $1,636,000 | -27.1% | 66,239 | -2.1% | 0.00% | 0.0% |
Q1 2022 | $2,245,000 | +1.7% | 67,641 | +0.2% | 0.00% | 0.0% |
Q4 2021 | $2,207,000 | -23.0% | 67,487 | -1.3% | 0.00% | 0.0% |
Q3 2021 | $2,866,000 | +5.9% | 68,380 | -1.8% | 0.00% | 0.0% |
Q2 2021 | $2,706,000 | +29.5% | 69,660 | +13.7% | 0.00% | 0.0% |
Q1 2021 | $2,089,000 | -22.3% | 61,240 | +3.3% | 0.00% | 0.0% |
Q4 2020 | $2,688,000 | +64.8% | 59,270 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $1,631,000 | -30.3% | 59,270 | -6.7% | 0.00% | 0.0% |
Q2 2020 | $2,340,000 | +12.6% | 63,540 | -1.0% | 0.00% | 0.0% |
Q1 2020 | $2,079,000 | -19.3% | 64,200 | +2.1% | 0.00% | 0.0% |
Q4 2019 | $2,575,000 | +15.5% | 62,850 | +0.3% | 0.00% | 0.0% |
Q3 2019 | $2,230,000 | -58.9% | 62,650 | -40.7% | 0.00% | -66.7% |
Q2 2019 | $5,426,000 | +17.1% | 105,630 | +30.7% | 0.00% | 0.0% |
Q1 2019 | $4,632,000 | -38.6% | 80,830 | -55.1% | 0.00% | -50.0% |
Q4 2018 | $7,548,000 | +32.6% | 179,930 | +138.6% | 0.01% | +50.0% |
Q3 2018 | $5,694,000 | -13.0% | 75,420 | -17.3% | 0.00% | -20.0% |
Q2 2018 | $6,546,000 | +700.2% | 91,230 | +233.0% | 0.01% | +400.0% |
Q1 2018 | $818,000 | -10.2% | 27,400 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $911,000 | +0.9% | 27,400 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $903,000 | +167.2% | 27,400 | +60.2% | 0.00% | – |
Q2 2017 | $338,000 | – | 17,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sonic GP LLC | 743,079 | $14,854,149 | 9.91% |
Aquilo Capital Management, LLC | 870,114 | $17,393,579 | 9.64% |
MPM BioImpact LLC | 656,718 | $13,127,793 | 2.64% |
ArchPoint Investors | 224,278 | $4,483,317 | 1.73% |
Redmile Group, LLC | 2,026,576 | $40,511,254 | 1.56% |
BOULDER HILL CAPITAL MANAGEMENT LP | 35,396 | $707,566 | 1.36% |
WS MANAGEMENT LLLP | 795,778 | $15,907,602 | 1.33% |
Redwood Wealth Management Group, LLC | 14,760 | $295,052 | 0.33% |
SummerHaven Investment Management, LLC | 21,298 | $425,747 | 0.27% |
HARBOR CAPITAL ADVISORS, INC. | 44,106 | $881,679 | 0.18% |